首页> 美国卫生研究院文献>PLoS Clinical Trials >Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

【2h】

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

机译：纤维化4指数对人类免疫缺陷病毒1型感染的患者开始抗逆转录病毒疗法（含或不含丙型肝炎病毒）的预后价值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo evaluate the Fibrosis (FIB)-4 index as a predictor of major liver-related events (LRE) and liver-related death (LRD) in human immunodeficiency virus (HIV) type-1 patients initiating combination antiretroviral therapy (cART).

机译：目的评估纤维化（FIB）-4指数作为开始联合抗逆转录病毒疗法（cART）的1型人类免疫缺陷病毒（HIV）患者主要肝相关事件（LRE）和肝相关死亡（LRD）的预测指标。

著录项

期刊名称 PLoS Clinical Trials
作者
Cristina Mussini; Patrizia Lorenzini; Massimo Puoti; Miriam Lichtner; Giuseppe Lapadula; Simona Di Giambenedetto; Andrea Antinori; Giordano Madeddu; Alessandro Cozzi-Lepri; Antonella d’Arminio Monforte; Andrea De Luca;
展开▼
作者单位

展开▼
年(卷),期 2010(10),12
年度 2010
页码 e0140877
总页数 14
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Acute clinical hepatitis by immune restoration in a human immunodeficiency virus/hepatitis B virus co-infected patient receiving antiretroviral therapy. [J] . Rouanet I, Peyriere H, Mauboussin JM, European journal of gastroenterology and hepatology . 2003,第1期

机译：在接受抗逆转录病毒治疗的人类免疫缺陷病毒/乙型肝炎病毒合并感染的患者中，通过免疫恢复进行的急性临床肝炎。
2. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort [J] . Chalouni Mathieu, Sogni Philippe, Miailhes Patrick, European journal of gastroenterology and hepatology . 2019,第11期

机译：仅肝硬化和纤维化-4更好地预测肝脏事件与Antrs Co13 Hepavih Cohort中的人类免疫缺陷病毒和丙型肝炎病毒共感染患者的血小板比指数相比。
3. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC) [J] . Trickey Adam, May Margaret T., Schommers Philipp, Clinical infectious diseases . 2017,第6期

机译：CD4：CD8比例和CD8计数人体免疫缺陷病毒感染患者死亡率的预后标志物抗逆转录病毒治疗：抗逆转录病毒治疗队列协作（ART-CC）
4. Fuzzy Decision of Drug Dosage for Type-1 Human Immunodeficiency Virus Infected Patients [C] . Na Fu, Wenjie Zhang, Xiangpeng Xie IEEE International Conference on Cloud Computing and Intelligent Systems . 2018

机译：1型人类免疫缺陷病毒感染患者用药剂量的模糊决策
5. The pathogenesis of human immunodeficiency virus in a cohort of patients co-infected with hepatitis C virus (Immune deficiency). [D] . Bowker, Samantha L. 2001

机译：在丙型肝炎病毒（免疫缺陷）合并感染的一组患者中，人类免疫缺陷病毒的发病机理。
6. Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana [O] . Motswedi Anderson, Simani Gaseitsiwe, Sikhulile Moyo, 2016

机译：在博茨瓦纳基于Truvada的联合抗逆转录病毒疗法的人类免疫缺陷病毒/乙型肝炎病毒合并感染患者中CD4 + T细胞恢复缓慢
7. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus [O] . Mussini, Cristina, Lorenzini, Patrizia, Puoti, Massimo, 2015

机译：纤维化4指数对人类免疫缺陷病毒1型感染的患者开始抗逆转录病毒疗法（含或不含丙型肝炎病毒）的预后价值

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

摘要

著录项

相似文献

相关主题

期刊订阅